Non-thyroid laboratory surveillance before treatment was limited, with only two patients checked for adrenal function, three for reproductive hormones, four for growth-related analytes, one for hypophysitis/abnormal prolactin, and one for diabetes. This evidence concerns the gene PRL and hypophysitis.